Medication info
Nomaropin Tablet 5/100 milligrams

Nomaropin Tablet 5/100 milligrams

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201504320 · Approved 2015.06.30 · Insurance code 657805620

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is suitable for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using amlodipine or losartan. Furthermore, for patients with stage 2 hypertension who require combination therapy to reach the target blood pressure, this medication can be used from the start to effectively manage blood pressure. In other words, this medication is utilized as a combination drug for the treatment of hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause severe harm or even fatal outcomes to the fetus when taken during pregnancy, especially in the second and third trimesters. Therefore, it must be discontinued immediately if pregnancy is confirmed. Patients with reduced blood volume, such as those on diuretics, may experience hypotension when starting this medication and should be monitored carefully. It should not be administered to patients who are allergic to any components of this medication, pregnant or breastfeeding women, patients with severe aortic stenosis, or patients in a state of shock. Caution should be exercised in patients with reduced blood volume, strict salt restriction, severe renal impairment, or hyperkalemia, with close monitoring by healthcare personnel as necessary. Dizziness or headaches may occur while taking this medication, necessitating caution during hazardous activities such as working at heights or driving. If any unusual symptoms or allergic reactions occur while taking the medication, immediate consultation with healthcare personnel is required, particularly if serious allergic reactions such as angioedema arise. Co-administration with other antihypertensive agents or specific medications may enhance effects or increase the risk of side effects, so patients must inform healthcare providers about all medications being taken. Pregnant or breastfeeding women should not take this medication, and if pregnancy is confirmed, it must be stopped immediately. The safety and efficacy of this medication in pediatric patients have not been established, and its use is not recommended. Severe hypotension or heart-related issues can occur in cases of overdose, so the prescribed dosage must be adhered to, and medical attention must be sought immediately in the event of overdose. This medication should be kept out of reach of children, and transferring it to a different container is not recommended.

Side effects

  • Hypotension
  • neonatal cranial development deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contractions
  • craniofacial malformations
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 172 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pituitary edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste abnormalities
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • skin erythematous lesions
  • maculopapular rash
  • heaviness
  • warmth sensation
  • reduced glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • limb pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • dental pain
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory disorders
  • migraine
  • neuropathic hypersensitivity
  • panic disorder
  • sleep disorders
  • tremor
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial bleeding
  • erythema
  • photosensitivity
  • sweating
  • erythema
  • blurred vision
  • eye burning sensation
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • urethral infection
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Moreover, it is best stored at room temperature between 1°C and 30°C, not in extremely hot or cold conditions.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.